Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tremoulet

Showing results (211-220 of 281) with videos related to

Pageof 29
Sort By:
Plos One|December 11, 2013
Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin GShohei Ogata, Chisato Shimizu, Alessandra Franco, et al.
The Pediatric Infectious Disease Journal|June 8, 2012
Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with FeverAndras Bratincsak, Venu D Reddy, Prashant J Purohit, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 31, 2016
Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department NotesSon Doan, Cleo K Maehara, Juan D Chaparro, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 1, 2025
Development and Validation of Multivariable Machine-Learning Models for the Prediction of Multisystemic Inflammatory Syndrome Outcomes in Latin American ChildrenDanilo Buonsenso, Luca Mastrantoni, Rolando Ulloa-Gutierrez, et al.
The Lancet. Child & Adolescent Health|October 29, 2021
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trialJane C Burns, Samantha C Roberts, Adriana H Tremoulet, et al.
Clinical and Translational Science|April 24, 2020
Population Pharmacokinetics of Metoclopramide in Infants, Children, and AdolescentsShufan Ge, Susan R Mendley, Jacqueline G Gerhart, et al.
Pediatric Research|June 22, 2022
Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assayRowan Kuiper, Victoria J Wright, Dominic Habgood-Coote, et al.
American Journal of Human Genetics|November 16, 2004
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformationsF Bergametti, C Denier, P Labauge, et al.
JAMA Network Open|May 18, 2023
Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced MyocarditisHarsita Patel, Amalia Sintou, Rasheda A Chowdhury, et al.
Plos One|February 10, 2016
Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile IllnessesZhen Li, Zhou Tan, Shiying Hao, et al.
Pageof 29

Showing results (211-220 of 281) with videos related to

Sort By:
Pageof 29
Plos One|December 11, 2013
Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin GShohei Ogata, Chisato Shimizu, Alessandra Franco, et al.
The Pediatric Infectious Disease Journal|June 8, 2012
Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with FeverAndras Bratincsak, Venu D Reddy, Prashant J Purohit, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 31, 2016
Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department NotesSon Doan, Cleo K Maehara, Juan D Chaparro, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 1, 2025
Development and Validation of Multivariable Machine-Learning Models for the Prediction of Multisystemic Inflammatory Syndrome Outcomes in Latin American ChildrenDanilo Buonsenso, Luca Mastrantoni, Rolando Ulloa-Gutierrez, et al.
The Lancet. Child & Adolescent Health|October 29, 2021
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trialJane C Burns, Samantha C Roberts, Adriana H Tremoulet, et al.
Clinical and Translational Science|April 24, 2020
Population Pharmacokinetics of Metoclopramide in Infants, Children, and AdolescentsShufan Ge, Susan R Mendley, Jacqueline G Gerhart, et al.
Pediatric Research|June 22, 2022
Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assayRowan Kuiper, Victoria J Wright, Dominic Habgood-Coote, et al.
American Journal of Human Genetics|November 16, 2004
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformationsF Bergametti, C Denier, P Labauge, et al.
JAMA Network Open|May 18, 2023
Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced MyocarditisHarsita Patel, Amalia Sintou, Rasheda A Chowdhury, et al.
Plos One|February 10, 2016
Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile IllnessesZhen Li, Zhou Tan, Shiying Hao, et al.
Pageof 29